Global Menopausal Hot Flashes Market 2017-2021

  • ID: 4268120
  • Report
  • Region: Global
  • 70 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • ALLERGAN
  • Bayer
  • Hisamitsu Pharmaceutical
  • iHealth Labs
  • Novartis
  • Novo Nordisk
  • MORE
About Menopausal Hot Flashes
Menopausal hot flashes are the symptoms of menopause. They refer to feelings of warmth occurring during menopause transition (which includes stages such as premenopause, perimenopause, and postmenopause). Hot flashes cause redness of the skin (known as flushing) and excessive sweating. The menopausal hot flashes market is growing moderately at the rate of 3.01% owing to the increase in aging population globally, especially in Western countries, such as the US, which is likely to increase the menopause and post menopause-related cases.

The analysts forecast the global menopausal hot flashes market to grow at a CAGR of 3.01% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global menopausal hot flashes market for 2017-2021. To calculate the market size, the report considers the revenue generated from the menopausal hot flashes solutions.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

The report, Global Menopausal Hot Flashes Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- ALLERGAN
- Bayer
- Pfizer
Other prominent vendors
- Hisamitsu Pharmaceutical
- iHealth Labs
- Novo Nordisk
- Novartis

Market drivers
- Change in lifestyle
- For a full, detailed list, view the full report

Market challenges
- Side effects
- For a full, detailed list, view the full report

Market trends
- Increasing awareness through social media marketing
- For a full, detailed list, view the full report

Key questions answered in this report
- What will the market size be in 2021 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • ALLERGAN
  • Bayer
  • Hisamitsu Pharmaceutical
  • iHealth Labs
  • Novartis
  • Novo Nordisk
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by distribution channel
  • Market overview
PART 07: Geographical segmentation
  • Market overview
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Proliferation of strategic initiatives and increase in product innovations
  • Increasing awareness through social media marketing
  • Migration of production and sales facilities to APAC
PART 11: Vendor landscape
  • Competitive scenario
PART 12: Key vendor analysis
  • ALLERGAN
  • Bayer
  • Pfizer
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Change in the world’s population by age 2010-2050 (%)
Exhibit 02: Global menopausal hot flashes market 2016 and 2021 (%)
Exhibit 03: Global menopausal hot flashes market 2016-2021 ($ millions)
Exhibit 04: Five forces analysis
Exhibit 05: Global menopausal hot flashes market by distribution channel 2016 and 2021
Exhibit 06: Opportunity analysis
Exhibit 07: Retail outlets in global menopausal hot flashes market 2016-2021 ($ millions)
Exhibit 08: Key retail factors and indicators
Exhibit 09: Online retail in global menopausal hot flashes market 2016-2021 ($ millions)
Exhibit 10: Internet users by region 2016 (%)
Exhibit 11: Global menopausal hot flashes market segmentation by geography 2016 and 2021
Exhibit 12: Snapshot of geographical segmentation 2016 and 2021
Exhibit 13: Menopausal hot flashes market in Americas 2016-2021 ($ millions)
Exhibit 14: Menopausal hot flashes market in EMEA 2016-2021 ($ millions)
Exhibit 15: Menopausal hot flashes market in APAC 2016-2021 ($ millions)
Exhibit 16: Global urban population 2015 (%)
Exhibit 17: Key takeaways
Exhibit 18: Key takeaways
Exhibit 19: Key takeaways
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • ALLERGAN
  • Bayer
  • Hisamitsu Pharmaceutical
  • iHealth Labs
  • Novartis
  • Novo Nordisk
  • MORE
New Report Released: – Global Menopausal Hot Flashes Market 2017-2021

The author of the report recognizes the following companies as the key players in the global menopausal hot flashes market: ALLERGAN, Bayer, and Pfizer.

Other Prominent Vendors in the market are: Hisamitsu Pharmaceutical, iHealth Labs, Novo Nordisk, and Novartis.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is increasing awareness through social media marketing. The rise in awareness about menopause and its symptoms through social media initiatives has equipped women to handle that stage better. An increase in the number of social network users globally is encouraging vendors and marketers to invest in social media marketing to increase sales and maximize profits. With many educated, young adult women using social networking sites, there is a significant opportunity for vendors and the governing bodies to utilize the internet and create awareness.”

According to the report, one of the major drivers for this market is change in lifestyle. In recent years, there has been a significant change in the lifestyles of people characterized by unhealthy food habits, consumption of alcohol, and smoking. Generally, smoking has antiestrogen effects in women that can contribute to early menopause. Women these days are increasingly indulging in adventurous activities and sports, including adventure treks, swimming, running, and working out. Although these activities have valuable effects on mood and cardiovascular and bone health, there is very little evidence that suggests these activities help in managing vasomotor instability symptoms, including hot flashes and night sweats.

Further, the report states that one of the major factors hindering the growth of this market is side effects. Though women's health products are increasingly becoming available, consumers are concerned about the negative side effects of these products. Through mediums such as the internet, the side effects of menopausal solutions like HRT are coming to light. Many prescription therapies for hot flashes, including venlafaxine (Effexor) and desvenlafaxine (Pristiq), are known to cause side effects, such as a change in bowel habits, nausea, and headache.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • ALLERGAN
  • Bayer
  • Pfizer
  • Hisamitsu Pharmaceutical
  • iHealth Labs
  • Novo Nordisk
  • Novartis
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll